|
|
TAN 08,160 J07A GSK
|
Cervarix Vaccine
|
3 - O - deacyl- 4- monophosphoryl lipid A 50 mcg/ml,Aluminium Hydroxide 0.5 mg,Human Papillomavirus type 16 L1 Protein 20 µg/0.5 ml,Human Papillomavirus type 18 L1 Protein 20 µg/0.5 ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TZ12H240
|
Rotarix Oral Suspension Vaccine
|
Human Rotavirus Live Attenuated R1X4414 Strain CCLD50 Not Less than 10000000 CCID50/dose
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TZ 17 H 0106
|
Polio Sabin One and Three (Oral)
|
Virus Polio Type 1, strain LSc, 2ab > 10(6.0) CCID50/0.1ml,Virus Polio Type 3, strain Leon 12a > 10(5.8) CCID50/0.1ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TZ 16 H 0230
|
Nimenrix vaccine
|
1conjugated to tetanus toxoid carrier protein 44 mcg/ml,Neisseria meningitidis group A polysaccharide1 5 mcg/ml,Neisseria meningitidis group C polysaccharide1 5 mcg/ml,Neisseria meningitidis group W-135 polysaccharide1 5 mcg/ml,Neisseria meningitidis group Y polysaccharide1 5 mcg/ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 V 0661
|
Rotarix
|
Di-sodium adipate 132.74 mg mg/ 1.5 ml,Dulbecco’s Modified Eagle’s Medium (DMEM) 2.26 mg mg/ 1.5 ml,Live attenuated Human Rotavirus RIX4414 Strain not less than 10^6.0 CCID50/dose,Sucrose 1.073g gram,Water for Injection q.s. ad 1.5ml ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TAN 05,645 J07A GSK
|
Engerix B
|
Hepatitis B Vaccine 10 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TAN 05,644 J07A GSK
|
Engerix B
|
Hepatitis B Vaccine 20 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|
|
|
TAN 05,645 J07A GSK
|
Engerix B Paediatric
|
Hepatitis B Vaccine 10 mcg/0.5ml
|
GlaxoSmithKline Biologicals SA
|
Registered/Compliant
|
Details →
|